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Abstract: The risk for many complex diseases is believed to be a result of the interactive effects of genetic and environmental factors. 
Developing efficient techniques to identify gene-environment interactions (GxE) is important for unraveling the etiologic basis of many 
modern day diseases including cancer. The problem of false positives and false negatives continues to pose significant roadblocks to 
detecting GxE and informing targeted public health screening and intervention. A heuristic gatekeeper method is presented to guide the 
selection of single nucleotide polymorphisms (SNPs) in the design phase of a GxE study.
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Introduction
Advances in bioinformatics and genomics have opened 
the door for personalized medicine, enabling epidemi-
ologists to identify genetic variations that predispose 
some,  but  not  others,  to  disease.  Single    nucleotide 
polymorphisms (SNPs), which on average occur in 
about every 1,000 base pairs throughout the human 
genome, also may be useful for determining variability 
in individual response to treatment and could poten-
tially lead to the development of novel therapeutics 
custom tailored to patients’ genetic profiles. However, 
studies often have failed to yield consistent findings 
or definitive results, in part because analyses have not 
accounted for gene-environment interactions (GxE).
While  genetics  play  a  significant  role  in  many 
  diseases, few common medical disorders are explained 
by a single SNP or genetic mutation. Rather, environ-
mental factors are thought to modulate an individu-
al’s genetic predisposition for certain diseases.1–3 In 
the case of GxE, risk for disease occurs only when 
genetic and environmental factors are present in com-
bination, while individual factors alone convey little 
or no risk for disease. Correctly identifying GxE is 
particularly difficult in the context of high density 
SNP arrays, because the number of multiple compari-
sons can be in the thousands.
In this paper, an efficient gatekeeper algorithm is 
presented to identify GxE. The technique involves 
computing  a  multiplicity  adjusted  lower  bound  on 
an indirect estimate for GxE. The indirect estimate is 
then used to independently screen for GxE in a direct 
disease association study in order to correctly identify 
risk or propensity for disease.
Indirect OR estimate and confidence 
interval (CI) for gxe
The odds ratio (OR) for environmental exposure (E) 
associated with disease (D) in the population may be 
expressed as
 
OR(E|D)=
P(E|D) P(E|D)
P(E|D) P(E|D)
. .
  (1)
Assuming that D is relatively rare in both exposed 
and  unexposed  populations,  and  that  genotype 
(G)  is  independent  of  environmental  exposure  (E)
[i.e., P(G|E)=P(G|E)=g]
_
,  equation  number  (1)  sim-
plifies to
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Considering the simple case when OR(GE –|D) = 
OR(G –E|D) = 1, the OR for GxE given disease may be 
written as
  OR(GE|D) =[ OR(E|D)1 +g]/g, -   (3)
where [OR(E|D)| -1]  g by unity constraints on the 
joint conditional probabilities. Treating (g) as fixed, 
the (1-α/2) × 100% CI for OR(GE|D) is approxi-
mately equal to
Methodology
The method for indirectly estimating the odds ratio 
(OR) for GxE from a case-control study and the tech-
nique for computing multiplicity corrected confidence 
intervals  for  a  relative  effects  estimate  have  been 
separately described in previous publications and are 
only briefly summarized below.4,5 Their combination 
forms the basis for the procedure to screen for GxE.
where  z(1-α/2)  is  the  (1-α/2)  ×  100  percentile  of  a 
standard normal distribution.
Multiplicity corrected CIs
Given a set of (i) SNPs, the P value corresponding to the 
statistical significance of OR(GE|D)i is computed as
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and  LCI  is  the  (1-α/2)  ×  100%  lower  CI  from 
equation 4. Ordering the P values (pi’s) from the lowest 
to highest values, i.e., p(1)# p(2)# ... p(i)# ... p(n)  (with 
arbitrary ordering in the case of ties), the multiplicity 
corrected P values denoted by “*” are   computed as
pp () jj nj
* () , =- +1   (8)
where j ranges from 1 to n in a 1:1 identity map-
ping with the i values, and  p()
*
j  is bounded by unity. 
The multiplicity corrected (1-α/2) × 100% CI for 
OR(GE|D)(i) is then computed as
CI =O RG ED SE OR(GE|D (1 /2)
*
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Screening for gxe in a direct  
association study
A SNP will be selected as a possible candidate in 
a direct disease association study for GxE if the 
(1-α/2)  ×  100%  multiplicity  corrected  lower  CI 
(MCLCI)  estimate  for  OR(GE|D)  is  greater  than 
an  a  priori  specified  threshold  value,  for  exam-
ple, OR = 3.0. Letting α1 and α2 denote the type I 
error for the indirect and direct tests, the statistical 
  significance of the overall procedure will be pro-
tected at α # α1 + α2, where the upper bound holds 
under  independence  of  the  indirect  and  direct 
tests. The significance level of the likelihood ratio 
test for the global null hypothesis β = 0, where β 
denotes the vector of β coefficients in a direct mul-
tivariable logistic regression model, may be set to 
a nominal value (e.g., #0.001), such that the sig-
nificance level for the overall procedure (indirect 
and direct combined) will be protected at an α-level 
(7)
only slightly greater than the type I error for the 
indirect test. Furthermore, the total number of SNPs 
allowed to enter the direct model may be fixed at a 
small number, for example #10, based on the rank 
order of the lower 95% CIs for SNPs passing the 
OR threshold value.
In practice, a significant gain in power may be real-
ized by using a meta-analysis estimate for OR(E|D) 
and 95% CI. Because a meta-analysis combines sev-
eral studies, the resulting confidence interval will be 
more precise than a single case-control estimate of 
the effect.
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example (hypothetical)
A  population-based  meta-analysis  of  several  case-
control studies estimates that children living on a farm 
have a 1.5-fold OR(E|D) (95% CI = 1.1676 – 1.9270) 
for childhood brain cancer compared with controls. The 
aim of a future association study is to determine whether 
GxE  are  occurring  between  a  panel  of  100  innate 
immunity SNPs and exposure to farm life. The study 
investigator is interested in finding interactions with an 
OR(GE|D)  3.0. The population allele frequencies (g) 
for the 100 SNPs and computed 95% MCLCI for the 
indirect estimates of OR(GE|D) are shown in Table 1. 
Upon examining Table 1, the investigator observes that 
7 SNPs (highlighted in gray in the 3 rightmost col-
umns) have a MCLCI  3.0 for the indirect estimate of 
OR(GE|D) and these will be included in a new associa-
tion study to directly test for GxE. Assuming that the 
type I error rate for the direct test will be controlled 
at α2 = 0.001, the statistical   significance of the overall 
procedure will be protected at α # 0.051.Efird
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Power and sample size computation
Power and sample size for the direct study may be 
computed using standard maximum likelihood meth-
ods for a logistic regression model and setting the 
α-level equal to α2.6 When the joint distribution of 
covariates is unknown, the sample size for a mul-
tivariable  model  may  be  estimated  by  multiplying 
the univariate result times a variance inflation factor 
1/(1 1.2,3...p
2 −ρ ), where ρ1.2,3...p
2  denotes the squared mul-
tiple correlation coefficient and p equals the number 
of model covariates.7 In the example above, approxi-
mately  n1  =  260  cases  and  n2  =  260  controls  are 
needed in a direct study to have at least 80% power 
to detect an OR(GE|D)  3.18 (corresponding to the 
LCI of the minimum SNP passing the threshold for 
entrance into the direct model; upper right hand value 
in highlighted region of Table 1) at the α2 = 0.001 
level of statistical   significance (2-sided test), given 
ρ1.2,3...p
2 = 02 .,   P(E)  =  0.10  and  P(GE)  =  (0.88)
(0.10) = 0.088.8 Accordingly, the overall test proce-
dure is protected at α # 0.051 (i.e., α1 + α2 = 0.05 + 
0.001 = 0.051).
For  models  involving  non-null  main  effects  [i.e., 
P(G = 1, E = 0) ≠ 1 and/or P(G = 0, E = 1) ≠ 1], power may 
be computed by excluding these effects from the sample 
space when estimating the power for OR(GE|D).
Discussion
To  the  best  of  our  knowledge,  this  method  is  the 
first  to  screen  for  GxE  using  an  indirect  estimate 
for  OR(GE|D).  Statistical  power  is  significantly 
increased in this approach by eliminating SNPs prior 
Table 1. Multiplicity corrected 95% lower confidence intervals (LCI) for OR(GE|D) given the population allele frequency (g) 
for 100 innate immunity SNPs and OR(E|D) = 1.5 (95% LCI = 1.1676). 
g* OR 
(GE|D)
Multiplicity 
corrected 
95% LcI
g* OR 
(GE|D)
Multiplicity 
corrected 
95% LcI
g* OR 
(GE|D)
Multiplicity 
corrected 
95% LcI
g* OR 
(GE|D)
Multiplicity 
corrected 
95% LcI
74.0 1.68 1.24 49.4 2.01 1.21 39.4 2.27 1.25 26.8 2.87 1.48
73.0 1.68 1.22 49.0 2.02 1.21 39.0 2.28 1.26 25.8 2.94 1.51
72.0 1.69 1.21 48.6 2.03 1.21 38.6 2.30 1.26 24.8 3.02 1.54
71.0 1.70 1.20 48.2 2.04 1.21 38.2 2.31 1.27 23.8 3.10 1.58
70.0 1.71 1.19 47.8 2.05 1.21 37.8 2.32 1.27 22.8 3.19 1.62
69.0 1.72 1.19 47.4 2.05 1.21 37.4 2.34 1.27 21.8 3.29 1.66
68.0 1.74 1.18 47.0 2.06 1.21 37.0 2.35 1.28 20.8 3.40 1.71
67.0 1.75 1.18 46.6 2.07 1.21 36.6 2.37 1.28 19.8 3.53 1.76
66.0 1.76 1.18 46.2 2.08 1.21 36.2 2.38 1.29 18.8 3.66 1.82
65.0 1.77 1.18 45.8 2.09 1.21 35.8 2.40 1.29 17.8 3.81 1.89
64.0 1.78 1.17 45.4 2.10 1.21 35.4 2.41 1.30 16.8 3.98 1.96
63.0 1.79 1.17 45.0 2.11 1.22 35.0 2.43 1.30 15.8 4.16 2.04
62.0 1.81 1.17 44.6 2.12 1.22 34.6 2.45 1.31 14.8 4.38 2.14
61.0 1.82 1.17 44.2 2.13 1.22 34.2 2.46 1.32 13.8 4.62 2.25
60.0 1.83 1.17 43.8 2.14 1.22 33.8 2.48 1.32 12.8 4.91 2.38
59.0 1.85 1.18 43.4 2.15 1.22 33.4 2.50 1.33 11.8 5.24 2.53
58.0 1.86 1.18 43.0 2.16 1.23 33.0 2.52 1.33 10.8 5.63 2.70
57.0 1.88 1.18 42.6 2.17 1.23 32.6 2.53 1.34 9.8 6.10 2.92
56.0 1.89 1.18 42.2 2.18 1.23 32.2 2.55 1.35 8.8 6.68 3.18
55.0 1.91 1.18 41.8 2.20 1.23 31.8 2.57 1.35 7.8 7.41 3.51
54.0 1.93 1.19 41.4 2.21 1.24 31.4 2.59 1.36 6.8 8.35 3.94
53.0 1.94 1.19 41.0 2.22 1.24 31.0 2.61 1.37 5.8 9.62 4.52
52.0 1.96 1.19 40.6 2.23 1.24 29.8 2.68 1.40 4.8 11.42 5.34
51.0 1.98 1.20 40.2 2.24 1.25 28.8 2.74 1.42 3.8 14.16 6.60
49.8 2.00 1.20 39.8 2.26 1.25 27.8 2.80 1.45 2.8 18.86 8.80
Notes: The lightly highlighted area in the lower right hand corner of the table denotes the 7 SNPs that have multiplicity corrected 95% lower confidence 
intervals (MCLCI) exceeding the a priori specified threshold value of 3.0. The value 3.18 in the darkly highlighted area in the upper right hand corner of the 
above region corresponds to the MCLCI of the minimum SNP passing the threshold for entrance into the direct model. This value is used to conservatively 
estimate power, as higher values in the same column beneath 3.18 will yield smaller sample size estimates.
*expressed as a percentage.Algorithm for detecting gxe
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to    conducting  a  direct  association  study  of  GxE. 
  Furthermore, study cost is greatly reduced since fewer 
SNPs need to be genotyped.
The approach has several advantages. For example, 
the derived indirect estimate requires only knowledge 
of the OR for environmental exposure OR(E|D) and 
the population allele frequency (g). Also, the model 
can detect interactions even when the OR for an envi-
ronmental effect is null, i.e., OR(E|D) = 1.
An indirect estimate for OR(GE|D) can be com-
puted  regardless  of  whether  a  biologic  rationale 
exists for the underlying effect. Since the inclusion 
of  biologically  irrelevant  or  non-functional  SNPs 
will inflate type I error, pathway analysis and other 
molecular techniques are recommended to determine 
the relevance of SNPs prior to analysis.9
The face validity of the method is based on estab-
lished probabilistic principles and theory.10–12 None-
theless, further validation of the technique will require 
testing its ability to detect biologically and clinically 
meaningful  results  that  hold  under  replication  in 
future  independent  studies.  Furthermore,  since  the 
multiplicity corrected CIs used in the indirect screen-
ing phase of the method were derived heuristically 
and represent approximate estimates of the true inter-
val widths, re-sampling methods are recommended in 
situations requiring exact coverage.
A practical limitation of the method is that geno-
type must be independent of environmental exposure. 
This assumption may be violated, for example, when 
an underlying gene affects behavior such that an indi-
vidual is predisposed to seek (or avoid) the environ-
mental exposure (e.g., a gene that causes craving for 
alcohol). Additionally, the method does not account 
for complex gene-environment interactions that may 
underlie multifactorial diseases.
An  implicit  assumption  of  the  method  is  that 
estimates for OR(E|D) and (g) remain unchanged 
in the population under consideration in the direct 
association study. However, this may not hold true 
when samples are collected based on strict popu-
lation  stratification  or  the  target  population  has 
changed  over  time. Accordingly,  a  prudent  com-
parison of known epidemiologic characteristics for 
the indirect and direct populations is advised prior 
to the implementation of this method. Additionally, 
the user must use caution in the interpretation of 
results when the decimal precision of estimates are 
limited.
When the allelic frequency of SNPs is very low, the 
multiplicity adjusted P values will approach zero. To 
remedy this limitation, a GMP-based   implementation 
of the Schonhage-Strassen algorithm may be used to 
perform arbitrary-precision arithmetic.13,14 This algo-
rithm uses fast Fourier transforms in rings with 22n+1 
elements  to  enable  multiplicative  computation  of 
  factors near absolute zero.
The ultimate success of detecting GxE will depend 
on  the  accurate  and  precise  measurement  of  envi-
ronmental exposures on par with recent advances in 
genotyping technology. For many diseases, this will 
entail  determining  life-course  environmental  expo-
sures from birth onward.1 Parsimonious questionnaire 
design and the use of targeted biomarkers will play a 
key role in assessing environmental exposures in the 
context of GxE.
In  summary,  the  failure  to  account  for  multi-
plicity in large scale GxE studies may lead to the 
misinterpretation  of  results.  Furthermore,  disease 
association studies for GxE are expensive and time 
consuming, and careful control of these factors is 
important to consider in study design.15 The method 
presented in this paper offers an easy to implement 
and efficient means to identify GxE that will pro-
vide more efficacious use of research and clinical 
resources.
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